NCT02379520 2026-04-15
HESTIA
Baylor College of Medicine
Phase 1 Completed
Clinical Trials
4 trialsNCT03686124 2026-04-13
ACTengine
Immatics US, Inc.
Phase 1/2 Recruiting
NCT05533697 2026-04-03
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
ModernaTX, Inc.
Phase 1/2 Recruiting
NCT03355976 2026-04-02
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Brown University
Phase 2 Active not recruiting